Detailansicht

Wissensnetz

Person

Dirk Schadendorf (1960-)

Arzt

Name	Dirk Schadendorf
Zeit	1960- (Lebensdaten)
Ort	Hamburg (Geburtsort) Essen (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Arzt (charakteristischer Beruf)
Variante	D. Schadendorf
Beziehung	Deutsches Krebsforschungszentrum (1997-2008) Universität Heidelberg. Medizinische Fakultät (Lehrauftrag) Universität Duisburg-Essen
Weitere Angaben	Professor; Facharzt für Dermatologie, Venerologie, Dermatoonkologie u. Allergologie; Klinik für Dermatologie, Universitätsklinikum Essen; 1997-2008: Leiter der Abteilung "Klinische Kooperationseinheit für Dermatoonkologie" am DKFZ Heidelberg; Lehrbeauftragter an der Medizinischen Fakultät der Universität Heidelberg
Quelle	Kürschner Gelehrte 2001
Datensatztyp	Person
GND-Nummer	11142576X
Datensatz-ID	11142576X
Beteiligt an alle anzeigen Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark Influence of adjuvant therapies on organ‐specific recurrence of cutaneous melanoma: a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg Influence of adjuvant therapies on organ‐specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg Robustness of convolutional neural networks in recognition of pigmented skin lesions Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial Changes in body mass index, weight, and waist-to-hip ratio over five years in HIV-positive individuals in the HIV Heart Aging Study compared to the general population Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – an evaluation of the multicenter prospective skin cancer registry ADOREG Model soups improve performance of dermoscopic skin cancer classifiers Real-World Therapy with Pembrolizumab : Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct A benchmark for neural network robustness in skin cancer classification Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients Immune Checkpoint Blockade for Metastatic Uveal Melanoma : Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks : Systematic Review Skin cancer classification via convolutional neural networks : systematic review of studies involving human experts Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53 Integrated molecular drivers coordinate biological and clinical states in melanoma Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia: a prospective study Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma Effects of Label Noise on Deep Learning-Based Skin Cancer Classification Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies Dabrafenib und Trametinib : Kombinationstherapie bei erwachsenen Patienten mit einer BRAF-V600-Mutation Fortgeschrittenes Melanom : Einsatz der zielgerichteten Kombination Cobimetinib/Vemurafenib sowie Wirksamkeit bei Patienten mit erhöhter LDH Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients Fortgeschrittenes Melanom als Herausforderung : zielgerichtete Kombinationstherapie verbessert das Überleben Hautklinik - Universitätsklinikum Essen Willingness to pay for a cure of low-risk melanoma patients in Germany A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma Prolongation of the QTc interval in HIV-infected individuals compared to the general population Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term Therapy Optimale Systemtherapie beim kutanen Melanom Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study Checkpointinhibitoren Update der S3-Leitlinie zum malignen Melanom : Aktuelle Empfehlungen für das fortgeschrittene Melanom Optimale Systemtherapie beim kutanen Melanom The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression Mykotische und bakterielle Infektionen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Dirk Schadendorf (1960-)

Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark

Influence of adjuvant therapies on organ‐specific recurrence of cutaneous melanoma: a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg

Influence of adjuvant therapies on organ‐specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg

Robustness of convolutional neural networks in recognition of pigmented skin lesions

Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial

Changes in body mass index, weight, and waist-to-hip ratio over five years in HIV-positive individuals in the HIV Heart Aging Study compared to the general population

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions

Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG

MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – an evaluation of the multicenter prospective skin cancer registry ADOREG

Model soups improve performance of dermoscopic skin cancer classifiers

Real-World Therapy with Pembrolizumab : Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry

Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct

Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct

A benchmark for neural network robustness in skin cancer classification

Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients

Immune Checkpoint Blockade for Metastatic Uveal Melanoma : Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis

Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis

Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks : Systematic Review

Skin cancer classification via convolutional neural networks : systematic review of studies involving human experts

Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53

Integrated molecular drivers coordinate biological and clinical states in melanoma

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia: a prospective study

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Effects of Label Noise on Deep Learning-Based Skin Cancer Classification

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Dabrafenib und Trametinib : Kombinationstherapie bei erwachsenen Patienten mit einer BRAF-V600-Mutation

Fortgeschrittenes Melanom : Einsatz der zielgerichteten Kombination Cobimetinib/Vemurafenib sowie Wirksamkeit bei Patienten mit erhöhter LDH

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Fortgeschrittenes Melanom als Herausforderung : zielgerichtete Kombinationstherapie verbessert das Überleben

Hautklinik - Universitätsklinikum Essen

Willingness to pay for a cure of low-risk melanoma patients in Germany

A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma

Prolongation of the QTc interval in HIV-infected individuals compared to the general population

Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term Therapy

Optimale Systemtherapie beim kutanen Melanom

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Checkpointinhibitoren

Update der S3-Leitlinie zum malignen Melanom : Aktuelle Empfehlungen für das fortgeschrittene Melanom

Optimale Systemtherapie beim kutanen Melanom

The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression

Mykotische und bakterielle Infektionen